Indong, Kiarra Suzette G.
HRN: 22-29-00 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2022
CEFUROXIME 750MG (VIAL)
12/06/2022
12/12/2022
IV DRIP
335 Mg
Q8
ATP
Waiting Final Action
02/17/2024
CEFUROXIME 750MG (VIAL)
02/17/2024
02/24/2024
IV
400mg
Q8H
PCAP C
Waiting Final Action